Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia

Por Mozas, Pablo, Rivas-Delgado, Alfredo, Baumann, Tycho, Villamor, Neus, Ortiz-Maldonado, Valentín, Aymerich, Marta, Costa, Dolors, Navarro, Alba, Giné, Eva, López-Guillermo, Armando, Montserrat, Emili, Delgado, Julio
Publicado no Blood Cancer J (2018)

The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational sta...

Por Vidal-Crespo, Anna, Rodriguez, Vanina, Matas-Cespedes, Alba, Lee, Eriong, Rivas-Delgado, Alfredo, Giné, Eva, Navarro, Alba, Beà, Sílvia, Campo, Elias, López-Guillermo, Armando, Lopez-Guerra, Monica, Roué, Gaël, Colomer, Dolors, Pérez-Galán, Patricia
Publicado no Haematologica (2017)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

Por Puiggros, Anna, Collado, Rosa, Calasanz, Maria José, Ortega, Margarita, Ruiz-Xivillé, Neus, Rivas-Delgado, Alfredo, Luño, Elisa, González, Teresa, Navarro, Blanca, García-Malo, MaDolores, Valiente, Alberto, Hernández, José Ángel, Ardanaz, María Teresa, Piñan, María Ángeles, Blanco, María Laura, Hernández-Sánchez, María, Batlle-López, Ana, Salgado, Rocío, Salido, Marta, Ferrer, Ana, Abrisqueta, Pau, Gimeno, Eva, Abella, Eugènia, Ferrá, Christelle, Terol, María José, Ortuño, Francisco, Costa, Dolors, Moreno, Carol, Carbonell, Félix, Bosch, Francesc, Delgado, Julio, Espinet, Blanca
Publicado no Oncotarget (2017)